Literature DB >> 19230712

Financial remuneration for clinical and behavioral research participation: ethical and practical considerations.

Jennifer Permuth-Wey1, Amy R Borenstein.   

Abstract

PURPOSE: Although the practice of providing payment to clinical research participants has been ongoing for more than a century, it remains an ethically controversial topic among members of the research community. The aims of this commentary are to summarize ethical and practical considerations regarding financial remuneration of research participants and to make recommendations for researchers contemplating this practice.
METHODS: A PubMed search was conducted to explore the ethical implications surrounding financial remuneration and review the body of empiric data on this topic.
RESULTS: Financial remuneration is perceived to be ethically acceptable by many researchers and research participants and can be helpful in the recruitment process. It is recommended that when investigators are contemplating whether to offer payment to research participants, they should consider the nature of the study and the potential benefits and risks to the participants, institutional or organizational guidelines, and cultural and societal norms specific to the population being studied.
CONCLUSIONS: Financial remuneration has the ability to serve as a sign of appreciation for the contributions of research participants and a way to facilitate clinical and behavioral research.

Entities:  

Mesh:

Year:  2009        PMID: 19230712     DOI: 10.1016/j.annepidem.2009.01.004

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  16 in total

1.  "Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implications.

Authors:  Roberto Abadie; Brandon Brown; Celia B Fisher
Journal:  Ethics Behav       Date:  2018-11-05

2.  Why do we pay? A national survey of investigators and IRB chairpersons.

Authors:  Elizabeth Ripley; Francis Macrina; Monika Markowitz; Chris Gennings
Journal:  J Empir Res Hum Res Ethics       Date:  2010-09       Impact factor: 1.742

3.  Who's doing the math? Are we really compensating research participants?

Authors:  Elizabeth Ripley; Francis Macrina; Monika Markowitz; Chris Gennings
Journal:  J Empir Res Hum Res Ethics       Date:  2010-09       Impact factor: 1.742

4.  "We're giving you something so we get something in return": Perspectives on research participation and compensation among people living with HIV who use drugs.

Authors:  Alexandra B Collins; Carol Strike; Adrian Guta; Rosalind Baltzer Turje; Patrick McDougall; Surita Parashar; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2016-10-22

5.  Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.

Authors:  Andrew Garland; Kevin Weinfurt; Jeremy Sugarman
Journal:  Clin Trials       Date:  2021-12       Impact factor: 2.486

6.  Social Drinking Groups and Risk Experience in Nightclubs: Latent Class Analysis.

Authors:  Beth Bourdeau; Brenda A Miller; Robert B Voas; Mark B Johnson; Hilary F Byrnes
Journal:  Health Risk Soc       Date:  2017-10-20

7.  What are fair study benefits in international health research? Consulting community members in Kenya.

Authors:  Maureen Njue; Francis Kombe; Salim Mwalukore; Sassy Molyneux; Vicki Marsh
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  Benefits in cash or in kind? A community consultation on types of benefits in health research on the Kenyan Coast.

Authors:  Maureen Njue; Sassy Molyneux; Francis Kombe; Salim Mwalukore; Dorcas Kamuya; Vicki Marsh
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Payment for participation in clinical research: Review of proposals submitted to the ethics committees.

Authors:  Padmaja A Marathe; Raakhi K Tripathi; Yashashri C Shetty; Sunil S Kuyare; Sandhya K Kamat; Urmila M Thatte
Journal:  Perspect Clin Res       Date:  2018 Apr-Jun

10.  Non-Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment.

Authors:  Joanna P MacEwan; Komal Gupte-Singh; Lauren M Zhao; Karen L Reckamp
Journal:  MDM Policy Pract       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.